Value proposition

SPARK Neuro is committed to advancing the diagnosis of neurodegenerative diseases and cognitive impairment. Our FDA-approved solution, integrating AI with EEG brain scan technology, ensures more accurate and timely diagnosis. Serving medical providers, insurance companies, and pharmaceutical developers, we enhance patient care and drive better health outcomes.

Biometric Research, Biomarker Development, Central Nervous System, Medtech, Research, Alzheimer's Disease, Dementia, and Artificial Intelligence